Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand-Reference-Cited by-同舟云学术

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi‐centre 48‐week efficacy and safety study in Thailand

Published:2022-01 Issue:1 Volume:25 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc.

Author:

Phongsamart Wanatpreeya¹,Jantarabenjakul Watsamon²³,Chantaratin Sasitorn⁴,Anugulruengkitt Suvaporn²³,Suntarattiwong Piyarat⁵,Sirikutt Pakpen⁵,Kosalaraksa Pope⁶,Maleesatharn Alan¹,Chokephaibulkit Kulkanya¹^ORCID

Affiliation:

1. Department of Pediatrics Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

2. Department of Pediatrics Faculty of Medicine Chulalongkorn University Bangkok Thailand

3. Thai Red Cross AIDS Research Center (TRCARC) HIVNAT Bangkok Thailand

4. Division of Child and Adolescent Psychiatry Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

5. Queen Sirikit National Institute of Child Health Bangkok Thailand

6. Department of Pediatrics Faculty of Medicine Khon Kaen University Khon Kaen Thailand

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25862

Reference31 articles.

1. The challenges of success: adolescents with perinatal HIV infection

2. World Health Organization.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach.2nd ed.2016. Available fromhttps://www.who.int/hiv/pub/arv/arv‐2016/en/. Accessed 11 March 2021.

3. Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals;Mbuagbaw L;Cochrane Database Syst Rev,2016

4. A Systematic Review of the Psychiatric Side-Effects of Efavirenz

5. Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV;Endocrine Reviews;2023-08-09

2. Neuropsychiatric Adverse Events Following Antiretroviral Therapy in People Living with HIV: A Real-World Study of Dynamic Trends and Risk Factors in Hangzhou, China;Infection and Drug Resistance;2023-08